Quantification of breast cancer cells in peripheral blood samples by real-time RT-PCR

Anticancer Research

Volumn 32, Issue 12, 2012, Pages 5387-5391

  Zebisch, Michael ^a   Kölbl, Alexandra C ^a   Schindlbeck, Christian ^b   Neugebauer, Julia ^a   Heublein, Sabine ^a   Ilmer, Matthias ^c   Rack, Brigitte ^a   Friese, Klaus ^a   Jeschke, Udo ^a   Andergassen, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Clinic Traunstein   (Germany)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast carcinoma; CTC; Cytokeratin; MCF7; ZR 75 1 cells

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CELL STRAIN MCF 7; CIRCULATING TUMOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; KERATINS; MCF-7 CELLS; NEOPLASTIC CELLS, CIRCULATING; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84872553037     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ashworth TR: A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Australian Medical Journal 14: 146-147, 1869.
2. Pantel K and Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4(6): 448-456, 2004.
3. Ring A, Smith IE and Dowsett M: Circulating tumour cells in breast cancer. Lancet Oncol 5(2): 79-88, 2004.
4. Smerage JB and Hayes DF: The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer 94(1): 8-12, 2006.
5. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmuller G and Schlimok G: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342(8): 525-533, 2000.
6. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A and Pantel K: A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353(8): 793-802, 2005.
7. Franklin WA, Shpall EJ, Archer P, Johnston CS, Garza-Williams S, Hami L, Bitter MA, Bast RC and Jones RB: Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res Treat 41(1): 1-13, 1996.
8. Simpson SJ, Vachula M, Kennedy MJ, Kaizer H, Coon JS, Ghalie R, Williams S and Van Epps D: Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp Hematol 23 (10): 1062-1068, 1995.
9. Sloane JP, Ormerod MG, Imrie SF and Coombes RC: The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections. Br J Cancer 42(3): 392-398, 1980.
10. LLC V. veridex Cell Search Web Site. 2010.
11. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20): 6897-6904, 2004.
12. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW and Hayes DF: Circulating tumor cells versus imaging - predicting overall survival in metastatic breast cancer. Clin Cancer Res 12(21): 6403-6409, 2006.
13. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW and Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8): 781-791, 2004.
14. de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ and Raghavan D: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14(19): 6302-6309, 2008.
15. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Janicke F, Jackson S, Gornet T, Cristofanilli M and Pantel K: Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 13(3): 920-928, 2007.
16. Kurec AS, Baltrucki L, Mason DY and Davey FR: Use of the APAAP method in the classification and diagnosis of hematologic disorders. Clin Lab Med 8(1): 223-236, 1988.
17. Noack F, Schmitt M, Bauer J, Helmecke D, Kruger W, Thorban S, Sandherr M, Kuhn W, Graeff H and Harbeck N: A new approach to phenotyping disseminated tumor cells: methodological advances and clinical implications. Int J Biol Markers 15(1): 100-104, 2000.
18. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402-408, 2001.
19. Ghossein RA, Bhattacharya S, Rosai J: Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5(8): 1950-1960, 1999.
20. Hayes DF, Walker TM, Singh B, Vitetta ES, Uhr JW, Gross S, Rao C, Doyle GV and Terstappen LW: Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol 21(5): 1111-1117, 2002.
21. de Bono JS, Attard G, Adjei A, Pollak MN, Fong PC, Haluska P, Roberts L, Melvin C, Repollet M, Chianese D, Connely M, Terstappen LW and Gualberto A: Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor. Clin Cancer Res 13(12): 3611-3616, 2007.
22. Balbin M, Pendas AM, Uria JA, Jimenez MG, Freije JP and Lopez-Otin C: Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS 107(1): 45-53, 1999.
23. Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ and Lin SR: MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol Rep 22(5): 1119-1127, 2009.
24. Lafleur MA, Drew AF, de Sousa EL, Blick T, Bills M, Walker EC, Williams ED, Waltham M and Thompson EW: Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Int J Cancer 114(4): 544-554, 2005.
25. Selvamurugan N and Partridge NC: Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol Cell Biol Res Commun 3(4): 218-223, 2000.
26. Uria JA, Stahle-Backdahl M, Seiki M, Fueyo A and Lopez-Otin C: Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 57(21): 4882-4888, 1997.
27. Nikseresht M, Seghatoleslam A, Monabati A, Talei A, Ghalati FB and Owji AA: Overexpression of the novel human gene, UBE2Q2, in breast cancer. Cancer Genet Cytogenet 197(2): 101-106, 2010.
28. Fabre-Lafay S, Garrido-Urbani S, Reymond N, Goncalves A, Dubreuil P and Lopez M: Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17. J Biol Chem 280(20): 19543-19550, 2005.
29. Dontu G: Breast cancer stem cell markers - the rocky road to clinical applications. Breast Cancer Res 10(5): 110, 2008.